KRNY Stock Analysis: Kearny Financial | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 590m USD | 12M Return: 50.5% | US48716P1084 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.12M
EPS Trend: -21.1%
Qual. Beats: -1
Rev. Trend: 87.2%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Kearny Financial Corp. (NASDAQ: KRNY) is the holding company for Kearny Bank, a regional community bank headquartered in Fairfield, New Jersey, with origins dating back to 1884. The company provides a standard range of community banking products, including checking, savings, money market, and certificate of deposit accounts, along with personal loans and overdraft lines of credit. Its loan portfolio is heavily weighted toward commercial and residential real estate, including multi-family and nonresidential mortgage loans, commercial term loans and lines of credit, home equity products, and construction lending for multi-family and 1-4 family properties. The company also engages in investment activities to support its banking operations.
As a small-cap regional bank with a market capitalization of roughly $553M, Kearny operates within the U.S. regional/community banking segment, which typically derives the majority of net interest income from loan portfolios funded by local deposits. The companys notable emphasis on multi-family and commercial real estate lending is characteristic of Northeast-based community banks serving metropolitan-area landlords and small businesses.
- Net interest margin compresses as Fed cuts rates
- Multi-family loan concentration poses commercial real estate credit risk
- Deposit cost increases outpace loan yield expansion pressures margins
| Net Income: 36.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 0.21 > 1.0 |
| NWC/Revenue: 1.94k% < 20% (prev 334.7%; Δ 1.61k% < -1%) |
| CFO/TA 0.00 > 3% & CFO 37.7m > Net Income 36.3m |
| Net Debt (70.8m) to EBITDA (51.8m): 1.37 < 3 |
| Current Ratio: 34.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (63.2m) vs 12m ago 0.74% < -2% |
| Gross Margin: 50.82% > 18% (prev 44.14%; Δ 6.68% > 0.5%) |
| Asset Turnover: 4.50% > 50% (prev 4.44%; Δ 0.06% > 0%) |
| Interest Coverage Ratio: 0.28 > 6 (EBIT TTM 47.4m / Interest Expense TTM 169.0m) |
| A: 0.88 (Total Current Assets 6.94b - Total Current Liabilities 200.0m) / Total Assets 7.68b |
| B: 0.05 (Retained Earnings 350.0m / Total Assets 7.68b) |
| C: 0.01 (EBIT TTM 47.4m / Avg Total Assets 7.71b) |
| D: 0.11 (Book Value of Equity 766.7m / Total Liabilities 6.92b) |
| Altman-Z'' = 6.06 = AAA |
| DSRI: 1.00 (Receivables 5.86b/5.79b, Revenue 347.1m/343.5m) |
| GMI: 0.87 (GM 44.14% / 50.82%) |
| AQI: 0.98 (AQ_t 0.09 / AQ_t-1 0.09) |
| SGI: 1.01 (Revenue 347.1m / 343.5m) |
| TATA: -0.00 (NI 36.3m - CFO 37.7m) / TA 7.68b) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of September 27, 2026, the stock is trading at USD 9.36 with a total of 500,301 shares traded. Over the past week, the price has changed by -2.09%, over one month by -5.36%, over three months by +3.83% and over the past year by +50.46%.
Current recommended Stop Loss: 9.10 (which is 2.8% or 1.2 ATR below the current price).
Kearny Financial has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold KRNY.
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 10.7 | 14% |
P/E Trailing = 16.6786
P/E Forward = 11.4943
P/S = 3.3447
P/B = 0.7873
P/EG = 15.99
Revenue TTM = 347.1m USD
EBIT TTM = 47.4m USD
EBITDA TTM = 51.8m USD
Long Term Debt = 950.0m USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 1.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 70.8m USD (calculated: Debt 1.15b - CCE 1.08b)
Enterprise Value = 660.8m USD (590.0m + Debt 1.15b - CCE 1.08b)
Interest Coverage Ratio = 0.28 (Ebit TTM 47.4m / Interest Expense TTM 169.0m)
EV/FCF = 17.83x (Enterprise Value 660.8m / FCF TTM 37.1m)
FCF Yield = 5.61% (FCF TTM 37.1m / Enterprise Value 660.8m)
FCF Margin = 10.68% (FCF TTM 37.1m / Revenue TTM 347.1m)
Net Margin = 10.45% (Net Income TTM 36.3m / Revenue TTM 347.1m)
Gross Margin = 50.82% ((Revenue TTM 347.1m - Cost of Revenue TTM 170.7m) / Revenue TTM)
Gross Margin QoQ = 51.39% (prev 52.71%)
Tobins Q-Ratio = 0.09 (Enterprise Value 660.8m / Total Assets 7.68b)
Interest Expense / Debt = 14.70% (Interest Expense 169.0m / Debt 1.15b)
Taxrate = 23.50% (11.1m / 47.4m)
NOPAT = 36.3m (EBIT 47.4m * (1 - 23.50%))
Current Ratio = 34.68 (Total Current Assets 6.94b / Total Current Liabilities 200.0m)
Debt / Equity = 1.50 (Debt 1.15b / totalStockholderEquity, last quarter 766.7m)
Debt / EBITDA = 1.37 (Net Debt 70.8m / EBITDA 51.8m)
Debt / FCF = 1.91 (Net Debt 70.8m / FCF TTM 37.1m)
Total Stockholder Equity = 760.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.47% (Net Income 36.3m / Total Assets 7.68b)
RoE = 4.77% (Net Income TTM 36.3m / Total Stockholder Equity 760.1m)
RoCE = 2.77% (EBIT 47.4m / Capital Employed (Equity 760.1m + L.T.Debt 950.0m))
RoIC = 0.47% (NOPAT 36.3m / Invested Capital 7.66b)
WACC = 10.18% (E(590.0m)/V(1.74b) * Re(8.10%) + D(1.15b)/V(1.74b) * Rd(14.70%) * (1-Tc(0.23)))
Discount Rate = 8.10% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 99.01 | Cagr: 0.72%
[DCF] Terminal Value 72.29% ; FCFF base≈30.8m ; Y1≈35.3m ; Y5≈52.0m
[DCF] Fair Price = 8.23 (EV 590.9m - Net Debt 70.8m = Equity 520.1m / Shares 63.2m; r=10.18% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -21.10 | EPS CAGR: -4.31% | SUE: -1.89 | # QB: -1
Revenue Correlation: 87.15 | Revenue CAGR: 4.14% | SUE: 2.80 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.17 | Chg30d=-2.86% | Revisions=+25% | Analysts=3
EPS next Quarter (2026-12-31): EPS=0.19 | Chg30d=+0.92% | Revisions=+25% | Analysts=3
EPS current Year (2027-06-30): EPS=0.79 | Chg30d=-0.42% | Revisions=+0% | GrowthEPS=+33.3% | GrowthRev=+11.9%
EPS next Year (2028-06-30): EPS=0.99 | Chg30d=-0.50% | Revisions=+0% | GrowthEPS=+26.5% | GrowthRev=+11.1%
[Analyst] Revisions Ratio: +40% (up=2, down=0)